“HIV‑1 drug‑resistance mutations and related risk factors among HIV‑1‑positive individuals receiving first-line antiretroviral therapy” (2025) Universa Medicina, 44(1), pp. 57–64. doi:10.18051/UnivMed.2025.v44.57-64.